Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Patients with antiphospholipid antibodies (aPL) are at increased risk for arterial or venous thrombosis. There is, however, significant heterogeneity among patients according to clinical and ...

Provocation with aspirin in AIA patients produces airflow obstruction accompanied by the release of cysteinyl LTs into the urine and BAL fluid. [7, 8] LTC 4 synthase is the rate-limiting enzyme ...